HOME >> MEDICINE >> NEWS
Viagra significantly effective, well-tolerated for men taking multiple blood pressure treatments

NEW YORK, May 15, 2002 -- More than 80 percent of men taking two or more drugs for their high blood pressure reported improvement in their erections and their ability to have sexual intercourse after taking Viagra (sildenafil citrate) for 12 weeks to treat their erectile dysfunction (ED), according to data scheduled to be presented at the American Society of Hypertension 17th Annual Scientific Meeting.

The 12-week, study involved 562 men taking two or more antihypertensives drugs. The first six weeks of double-blind treatment was followed by an additional six weeks of open-label treatment with Viagra. After six weeks, Viagra significantly improved erections for 71 percent of the men versus 18 percent taking placebo. In addition, the Viagra group had significantly more successful intercourse attempts, 62 percent, compared to 26 percent on placebo. During the open label extension, more than 80 percent of men who received Viagra had improved erections and intercourse.

This study showed that Viagra is both well-tolerated and effective when used in conjunction with high blood pressure medications which is good news for men who are often forced to choose between treating their hypertension and staying sexually active, said Dr. Thomas G. Pickering of the Zena and Michael A. Weiner Cardiovascular Institute, Mount Sinai School of Medicine in New York.

Investigators did not observe any serious adverse events related to Viagra treatment. The majority of side effects were mild to moderate and short-lived, with the most common including headache, facial flushing, indigestion, dizziness, nasal congestion and abnormal vision. Less than 2 percent of Viagra- and placebo-treated patients discontinued the study due to side effects.

For many men, ED is often an underlying symptom signaling that there may be another significant health issue such as hypertension, said Dr. Pickering.

On average, the study participants had high blood pres
'"/>

Contact: Geoff Cook
212-733-5244
Porter Novelli
15-May-2002


Page: 1 2 3

Related medicine news :

1. U of M researcher says Viagra may cause permanent vision loss in some men
2. Viagra used in stroke recovery study
3. Younger men lead surge in Viagra use, study reveals
4. Viagra (R) can take effect in as little as 14 minutes in many men, study shows
5. Viagra for alleviation of pulmonary hypertension?
6. Viagra helps men with heart failure
7. First study of Viagra(R) in black men demonstrates treatment as effective, well tolerated
8. Mayo Clinic study shows no adverse heart effect for sildenafil (Viagra)
9. Beyond Viagra: other phosphodiesterase inhibitors are candidates for potential therapies
10. Viagra Prescribing Will Be Based On Financial Rather Than Clinical Reasoning
11. UK Faculty Members Find Way To Speed Response Of Viagra

Post Your Comments:
(Date:9/1/2015)... ... September 01, 2015 , ... With former IBMers among its founding ... since its inception more than 35 years ago. A pilot program begun by the ... - and, not just those intent on pursuing careers in these fields. The program ...
(Date:9/1/2015)... ... September 01, 2015 , ... Royal River Natural Foods, a locally-owned independent natural ... women for 19 years and found that, among those who had a stroke, people ... report is part of the September 2015 issue of “Natural Insights for Well Being,” ...
(Date:9/1/2015)... Boston, MA (PRWEB) , ... September 01, 2015 , ... ... the little-known and incurable disease, facioscapulohumeral muscular dystrophy (FSHD), will be the beneficiary of ... has the same mission – to raise awareness of the FSH Society and further ...
(Date:9/1/2015)... , ... September 01, 2015 , ... SC&H Group, a ... which includes being named a “Best of the Best” firm in the U.S., as ... named the “Best of the Best” in the U.S., selected exclusively on performance in ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... the 2015-2016 Distinguished Nurse Scholar-in Residence at the Institute of Medicine (IOM) of ... of Biomedical Informatics at Columbia University School of Nursing. A member of the ...
Breaking Medicine News(10 mins):Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2Health News:Columbia Nursing’s Suzanne Bakken Named Distinguished Institute of Medicine Nurse Scholar-in-Residence 2
(Date:9/1/2015)... , Sept. 1, 2015  Results from an interim ... demonstrate that 5g of idarucizumab enabled emergency surgery ... patients treated with dabigatran (Pradaxa ® dabigatran ... anticoagulant effect of dabigatran enabled patients to be ... time of 1.7 hours between administration of idarucizumab ...
(Date:9/1/2015)... 1, 2015   Ivenix Inc. , a ... system, closed on a $42M round of equity ... Cardinal Partners, CICA, Inc., Easterly Capital, Fidelity Biosciences, ... round. This financing will support the company,s efforts ... Partners LLC acted as the exclusive placement agent ...
(Date:9/1/2015)... 2015 Within just two years after reaching ... rapidly reached 3,000 employees worldwide. This increase is ... injectable drug delivery market and SHL,s effective commitment, ... in the design and manufacturing of auto injectors ... manufacturing capabilities, a lean supply chain, strong partnerships, ...
Breaking Medicine Technology:New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 2New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 3New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 4New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 5New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 6New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 7New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 8New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 9Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3SHL Group Reaches Major Milestone of 3000 Employees 2
Cached News: